SOCIOPSYCOLOGICAL IMPACTS AFFECTING PATIENTS WITH CHRONIC KIDNEY DISEASE

Journal Title: World Journal of Pharmaceutical Research - Year 2018, Vol 7, Issue 1

Abstract

Background: Chronic kidney disease (CKD) is a progressive, lifethreatening illness characterized by losing renal function over period of time (months, years), posing a fundamental existential problem on individuals and a burden on their families. Due to the life–long illness, majority of CKD patients may trigger physiologic, psychological, and social stressors at any point during the disease, thus, placing a barrier for them in maintaining the normal life-style and may also reduce their quality of life. Objectives: The present study has been designed to find out the prevalence of depression among CKD patients in central region of KSA and to evaluate their social life, personal relationships & quality of life. Material & Methods: It was an observational cross –sectional Hospital based study. The data was collected from 33 CKD patients of either sex from Haemodialysis units at King Khalid Hospital, Almajmaah and Hurameula General Hospital, Hurameula, Kingdom of Saudi Arabia. A pre-defined self validated questionnaire (Beck Depression Inventory) was used to measure the severity of depression. To evaluate the Quality of Life of CKD, WHOQOL questionnaire was adapted and modified to the current situation. Results: The prevalence of depression among CKD patients was 44.0%. Majority of the patients had depression at the beginning of the condition 29 (90.6%), About 3/4 of the patients 24 (75.0%) were leading normal social life despite of being diseased. Significant association was observed between depression scale and depression at the beginning of the condition (p=0.43), showing that majority of the patients had borderline depression (n=8, 27.6%), (n=7, 24.1%) had moderate depression, whereas, (n=6, 20.7%) had severe depression. Significant association was observed between depression scale and the QoL scale (p<0.001), showing that those with acceptable quality of life had borderline depression (n=9, 33.3%) and those with not acceptable quality of life, majority of them had severe depression (n=4, 80%). Conclusion: A high proportion of CKD patients experienced depression eventually resulting in an impaired quality of life.

Authors and Affiliations

Dr. Abdullah Ali Alkhathami

Keywords

Related Articles

THE INTERCONNECTION BETWEEN CELL PHONE USAGE AND EAR PROBLEMS AMIDST MEDICAL STUDENTS, TAIBAH UNIVERSITY

Background: Concerns regarding the potential physiological effects of exposure to radio frequency (RF) radiation have been increased recently. Objective: This study explores a relationship between the use of mobile phone...

ANTIMICROBIAL ACTIVITY OF EXTRACTS OF SPIDER WEB SILK

Spider silk extracts in in various solvents with different polarities were prepared and antibacterial and antifungal actives were carried out. Four bacterial strain bacillus subtillus, staphylococcus aureus, Escherichia...

SUBSTITUTED QUINAZOLINE A POTENTIAL DRUG CANDIDATE: AN OVERVIEW

Heterocycles are among the most frequently encountered scaffolds in drug and pharmaceutically relevant substances. A heterocyclic core is propitious for variations of substitution pattern during Structure Activity Relati...

INDICATIONS FOR CESAREAN SECTION IN A SAMPLE OF WOMEN IN BAGHDAD CITY

Background: cesarean section has traditionally performed when a vaginal would put the mother or baby's life at risk. Cesarean section rate has risen worldwide in the last decades, in 2009 it was 34% in the Unit State of...

A LITERATURE REVIEW ON MALLIKAI CHOORNAM A CLASSICAL SIDDHA FORMULATION FOR URINARY TRACT INFECTION(AZHAL NEER CHURUKKU)

Siddha system is one the traditional system of medicine practised in south India. Saint Yougi mentioned the signs and symptoms of Azhal Neer Churukku in Yougi vaithiya chinthamani may be correlated with that of Urinary T...

Download PDF file
  • EP ID EP618857
  • DOI -
  • Views 127
  • Downloads 0

How To Cite

Dr. Abdullah Ali Alkhathami (2018). SOCIOPSYCOLOGICAL IMPACTS AFFECTING PATIENTS WITH CHRONIC KIDNEY DISEASE. World Journal of Pharmaceutical Research, 7(1), 277-283. https://europub.co.uk/articles/-A-618857